Decreased extra-renal urate excretion is a common cause of hyperuricemia

Nature Communications

Volumn 3, Issue , 2012, Pages

  Ichida, Kimiyoshi ^a,b   Matsuo, Hirotaka ^c   Takada, Tappei ^d   Nakayama, Akiyoshi ^c,e   Murakami, Keizo ^d   Shimizu, Toru ^f   Yamanashi, Yoshihide ^d   Kasuga, Hiroshi ^d   Nakashima, Hiroshi ^c   Nakamura, Takahiro ^c,g   Takada, Yuzo ^c   Kawamura, Yusuke ^c   Inoue, Hiroki ^c   Okada, Chisa ^c   Utsumi, Yoshitaka ^c   Ikebuchi, Yuki ^d   Ito, Kousei ^d   Nakamura, Makiko ^a   Shinohara, Yoshihiko ^a   Hosoyamada, Makoto ^h   Sakurai, Yutaka ^c   Shinomiya, Nariyoshi ^c   Hosoya, Tatsuo ^b   Suzuki, Hiroshi ^d   more..

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^e Japan Air Self Defense Force   (Japan)

^f Midorigaoka Hospital   (Japan)

^g INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^h TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; URATE; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; ABCG2 PROTEIN, MOUSE; TUMOR PROTEIN; URIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HYPERURICEMIA; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; URINARY EXCRETION; ADULT; AGED; ANIMAL; DOWN REGULATION; GENETICS; KIDNEY; METABOLISM; MIDDLE AGED; MOUSE MUTANT; PATHOPHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

MUS;

ADULT; AGED; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; DOWN-REGULATION; HUMANS; HYPERURICEMIA; KIDNEY; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; NEOPLASM PROTEINS; URIC ACID;

EID: 84860306924     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1756     Document Type: Article

References (41)

1. Feig, D. I., Kang, D. H. & Johnson, R. J. Uric acid and cardiovascular risk. N. Engl. J. Med. 359, 1811-1821 (2008).
2. Edwards, N. L. The role of hyperuricemia in vascular disorders. Curr. Opin. Rheumatol. 21, 132-137 (2009).
3. Yeldandi, A. V. et al. Human urate oxidase gene: Cloning and partial sequence analysis reveal a stop codon within the fifth exon. Biochem. Biophys. Res. Commun. 171, 641-646 (1990). (Pubitemid 20289432)
4. Sorensen, L. B. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum. 8, 694-706 (1965).
5. Sica, D. A. & Schoolwerth, A. in Brenner and Rector's The Kidney (ed. B.M. Brenner) 645-649 (Saunders, 2004).
6. Boss, G. R. & Seegmiller, J. E. Hyperuricemia and gout. Classification, complications and management. N. Engl. J. Med. 300, 1459-1468 (1979). (Pubitemid 9216421)
7. Becker, M. A. in The Metabolic & Molecular Bases of Inherited Disease (eds Charles R. Scriver, Barton Childs, Kenneth W. Kinzler, & Bert Vogelstein) 2513-2535 (McGraw-Hill, 2001).
8. Wortmann, R. L. in Harrison's Principles of Internal Medicine (eds Anthony S. Fauci et al.) 2444-2449 (McGraw-Hill, 2008).
9. Ichida, K., Hosoyamada, M., Hosoya, T. & Endou, H. in Genetic Diseases of the Kidney (ed. Richard P. Lifton) 653-662 (Academic Press, 2009).
10. Enomoto, A. et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417, 447-452 (2002). (Pubitemid 34563537)
11. Li, S. et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 3, e194 (2007).
12. Döring, A. et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat. Genet. 40, 430-436 (2008). (Pubitemid 351454014)
13. Vitart, V. et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat. Genet. 40, 437-442 (2008). (Pubitemid 351450879)
14. Anzai, N. et al. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J. Biol. Chem. 283, 26834-26838 (2008).
15. Matsuo, H. et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am. J. Hum. Genet. 83, 744-751 (2008).
16. Dehghan, A. et al. Association of three genetic loci with uric acid concentration and risk of gout: A genome-wide association study. Lancet 372, 1953-1961 (2008).
17. Kolz, M. et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 5, e1000504 (2009).
18. Kamatani, Y. et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 42, 210-215 (2010).
19. Cheng, L. S. et al. Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am. J. Hum. Genet. 75, 498-503 (2004). (Pubitemid 39115318)
20. Woodward, O. M. et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl Acad. Sci. USA 106, 10338-10342 (2009).
21. Matsuo, H. et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: A function-based genetic analysis in a Japanese population. Sci. Transl. Med. 1, 5ra11 (2009).
22. Fridovich, I. The competitive inhibition of uricase by oxonate and by related derivatives of s-triazines. J. Biol. Chem. 240, 2491-2494 (1965).
23. Sorensen, L. B. & Levinson, D. J. Origin and extrarenal elimination of uric acid in man. Nephron 14, 7-20 (1975).
24. Shimizu, T. et al. PDZK1 regulates breast cancer resistance protein in small intestine. Drug Metab. Dispos. 39, 2148-2154 (2011).
25. Anzai, N. et al. The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J. Biol. Chem. 279, 45942-45950 (2004). (Pubitemid 39491587)
26. Huls, M. et al. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int. 73, 220-225 (2008).
27. Maliepaard, M. et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61, 3458-3464 (2001). (Pubitemid 32695041)
28. Doyle, L. A. & Ross, D. D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22, 7340-7358 (2003). (Pubitemid 37487163)
29. Zaka, R. & Williams, C. J. New developments in the epidemiology and genetics of gout. Curr. Rheumatol. Rep. 8, 215-223 (2006). (Pubitemid 44623971)
30. Wallace, S. L. et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 20, 895-900 (1977).
31. Puig, J. G. & Mateos, F. A. Clinical and biochemical aspects of uric acid overproduction. Pharm. World Sci. 16, 40-54 (1994). (Pubitemid 24142446)
32. Perez-Ruiz, F., Calabozo, M., Erauskin, G. G., Ruibal, A. & Herrero-Beites, A. M. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum. 47, 610-613 (2002). (Pubitemid 35461313)
33. Wortmann, R. L. Gout and hyperuricemia. Curr. Opin. Rheumatol. 14, 281-286 (2002). (Pubitemid 34439094)
34. Urano, W. et al. Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann. Rheum. Dis. 69, 1232-1234 (2010).
35. The guideline revising committee of Japanese Society of Gout and Nucleic Acid Metabolism in Guideline for the Management of Hyperuricemia and Gout (ed. The guideline revising committee of Japanese Society of Gout and Nucleic Acid Metabolism) 60-72 (Medical Review, 2010).
36. Ichida, K. et al. Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. J. Clin. Invest. 99, 2391-2397 (1997). (Pubitemid 27227716)
37. Daimon, M. et al. Large-scale search of SNPs for type 2 DM susceptibility genes in a Japanese population. Biochem. Biophys. Res. Commun. 302, 751-758 (2003). (Pubitemid 36294037)
38. Hayashi, H., Takada, T., Suzuki, H., Akita, H. & Sugiyama, Y. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11. Hepatology 41, 916-924 (2005). (Pubitemid 40462954)
39. Takada, T., Weiss, H. M., Kretz, O., Gross, G. & Sugiyama, Y. Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154. Drug Metab. Dispos. 32, 1272-1278 (2004). (Pubitemid 39410912)
40. Hall, I. H., Scoville, J. P., Reynolds, D. J., Simlot, R. & Duncan, P. Substituted cyclic imides as potential anti-gout agents. Life Sci. 46, 1923-1927 (1990). (Pubitemid 20205064)
41. Kitamura, Y. et al. Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann. Hum. Genet. 66, 183-193 (2002).